Skip to content

The effects of three different doses of sufentanil on changes in blood pressure and heart rate after laryngoscopy and intubation

The effects of three different doses of sufentanil on changes in blood pressure and heart rate after laryngoscopy and intubation and comparison with the control group

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190721044298N1
Enrollment
128
Registered
2020-01-29
Start date
2019-04-21
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The effect of sufentanil on heart rate, the effect of sufentanil on blood pressure. Adverse effect of intravenous anesthetics

Interventions

Intervention 1: First intervention group: Sufentanil recipient at a dose of 0.1 µg / kg. Intervention 2: Second intervention group: Suffentanil recipient at a dose of 0.2 µg / kg. Intervention 3: Thir

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: patient with ASA I-II that have 18 to 65 years old have elective surgery with general anesthesia with intubation

Exclusion criteria

Exclusion criteria: history of cardiovascular disease renal failure anti hypertension drug airway abnormality patient with difficult intubation possibility addiction

Design outcomes

Primary

MeasureTime frame
Heart rate in laryngoscopy and intubation. Timepoint: At baseline, immediately before laryngoscopy, 1, 3, 5 and 10 minutes after laryngoscopy. Method of measurement: Heart monitor.;Blood pressure in laryngoscopy and intubation. Timepoint: At baseline, immediately before laryngoscopy, 1, 3, 5 and 10 minutes after laryngoscopy. Method of measurement: Digital barometer device connected to the monitor.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Iravani

Esfahan University of Medical Sciences

kashani@mui.ac.ir+98 31 3233 0091

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026